176 related articles for article (PubMed ID: 35628605)
1.
Abou Khalil Y; Marmontel O; Ferrières J; Paillard F; Yelnik C; Carreau V; Charrière S; Bruckert E; Gallo A; Giral P; Philippi A; Bluteau O; Boileau C; Abifadel M; Di-Filippo M; Carrié A; Rabès JP; Varret M
Int J Mol Sci; 2022 May; 23(10):. PubMed ID: 35628605
[TBL] [Abstract][Full Text] [Related]
2. Additive Effect of
Marmontel O; Abou-Khalil Y; Bluteau O; Cariou B; Carreau V; Charrière S; Divry E; Gallo A; Moulin P; Paillard F; Peretti N; Rabès JP; Varret M; Carrié A; Di Filippo M
Arterioscler Thromb Vasc Biol; 2023 Jul; 43(7):e270-e278. PubMed ID: 37128917
[TBL] [Abstract][Full Text] [Related]
3. Global molecular analysis and APOE mutations in a cohort of autosomal dominant hypercholesterolemia patients in France.
Wintjens R; Bozon D; Belabbas K; MBou F; Girardet JP; Tounian P; Jolly M; Boccara F; Cohen A; Karsenty A; Dubern B; Carel JC; Azar-Kolakez A; Feillet F; Labarthe F; Gorsky AM; Horovitz A; Tamarindi C; Kieffer P; Lienhardt A; Lascols O; Di Filippo M; Dufernez F
J Lipid Res; 2016 Mar; 57(3):482-91. PubMed ID: 26802169
[TBL] [Abstract][Full Text] [Related]
4. APOE p.Leu167del mutation in familial hypercholesterolemia.
Awan Z; Choi HY; Stitziel N; Ruel I; Bamimore MA; Husa R; Gagnon MH; Wang RH; Peloso GM; Hegele RA; Seidah NG; Kathiresan S; Genest J
Atherosclerosis; 2013 Dec; 231(2):218-22. PubMed ID: 24267230
[TBL] [Abstract][Full Text] [Related]
5. Effect of mutations in LDLR and PCSK9 genes on phenotypic variability in Tunisian familial hypercholesterolemia patients.
Slimani A; Jelassi A; Jguirim I; Najah M; Rebhi L; Omezzine A; Maatouk F; Hamda KB; Kacem M; Rabès JP; Abifadel M; Boileau C; Rouis M; Slimane MN; Varret M
Atherosclerosis; 2012 May; 222(1):158-66. PubMed ID: 22417841
[TBL] [Abstract][Full Text] [Related]
6. The p.Leu167del Mutation in APOE Gene Causes Autosomal Dominant Hypercholesterolemia by Down-regulation of LDL Receptor Expression in Hepatocytes.
Cenarro A; Etxebarria A; de Castro-Orós I; Stef M; Bea AM; Palacios L; Mateo-Gallego R; Benito-Vicente A; Ostolaza H; Tejedor T; Martín C; Civeira F
J Clin Endocrinol Metab; 2016 May; 101(5):2113-21. PubMed ID: 27014949
[TBL] [Abstract][Full Text] [Related]
7. APOE gene variants in primary dyslipidemia.
Khalil YA; Rabès JP; Boileau C; Varret M
Atherosclerosis; 2021 Jul; 328():11-22. PubMed ID: 34058468
[TBL] [Abstract][Full Text] [Related]
8. Cosegregation of serum cholesterol with cholesterol intestinal absorption markers in families with primary hypercholesterolemia without mutations in LDLR, APOB, PCSK9 and APOE genes.
Baila-Rueda L; Pérez-Ruiz MR; Jarauta E; Tejedor MT; Mateo-Gallego R; Lamiquiz-Moneo I; de Castro-Orós I; Cenarro A; Civeira F
Atherosclerosis; 2016 Mar; 246():202-7. PubMed ID: 26802983
[TBL] [Abstract][Full Text] [Related]
9. Clinical characterization and mutation spectrum of German patients with familial hypercholesterolemia.
Grenkowitz T; Kassner U; Wühle-Demuth M; Salewsky B; Rosada A; Zemojtel T; Hopfenmüller W; Isermann B; Borucki K; Heigl F; Laufs U; Wagner S; Kleber ME; Binner P; März W; Steinhagen-Thiessen E; Demuth I
Atherosclerosis; 2016 Oct; 253():88-93. PubMed ID: 27596133
[TBL] [Abstract][Full Text] [Related]
10. Description of a large family with autosomal dominant hypercholesterolemia associated with the APOE p.Leu167del mutation.
Marduel M; Ouguerram K; Serre V; Bonnefont-Rousselot D; Marques-Pinheiro A; Erik Berge K; Devillers M; Luc G; Lecerf JM; Tosolini L; Erlich D; Peloso GM; Stitziel N; Nitchké P; Jaïs JP; ; Abifadel M; Kathiresan S; Leren TP; Rabès JP; Boileau C; Varret M
Hum Mutat; 2013 Jan; 34(1):83-7. PubMed ID: 22949395
[TBL] [Abstract][Full Text] [Related]
11. Spectrum of mutations in Italian patients with familial hypercholesterolemia: New results from the LIPIGEN study.
Pirillo A; Garlaschelli K; Arca M; Averna M; Bertolini S; Calandra S; Tarugi P; Catapano AL;
Atheroscler Suppl; 2017 Oct; 29():17-24. PubMed ID: 28965616
[TBL] [Abstract][Full Text] [Related]
12. Impact of rare variants in autosomal dominant hypercholesterolemia causing genes.
Calandra S; Tarugi P; Bertolini S
Curr Opin Lipidol; 2017 Jun; 28(3):267-272. PubMed ID: 28323660
[TBL] [Abstract][Full Text] [Related]
13. Molecular spectrum of autosomal dominant hypercholesterolemia in France.
Marduel M; Carrié A; Sassolas A; Devillers M; Carreau V; Di Filippo M; Erlich D; Abifadel M; Marques-Pinheiro A; Munnich A; Junien C; ; Boileau C; Varret M; Rabès JP
Hum Mutat; 2010 Nov; 31(11):E1811-24. PubMed ID: 20809525
[TBL] [Abstract][Full Text] [Related]
14. Genetic variation in APOB, PCSK9, and ANGPTL3 in carriers of pathogenic autosomal dominant hypercholesterolemic mutations with unexpected low LDL-Cl Levels.
Huijgen R; Sjouke B; Vis K; de Randamie JS; Defesche JC; Kastelein JJ; Hovingh GK; Fouchier SW
Hum Mutat; 2012 Feb; 33(2):448-55. PubMed ID: 22095935
[TBL] [Abstract][Full Text] [Related]
15. Genetic Analysis of Japanese Children Clinically Diagnosed with Familial Hypercholesterolemia.
Nagahara K; Nishibukuro T; Ogiwara Y; Ikegawa K; Tada H; Yamagishi M; Kawashiri MA; Ochi A; Toyoda J; Nakano Y; Adachi M; Mizuno K; Hasegawa Y; Dobashi K
J Atheroscler Thromb; 2022 May; 29(5):667-677. PubMed ID: 34011801
[TBL] [Abstract][Full Text] [Related]
16. Molecular genetics of familial hypercholesterolemia in Israel-revisited.
Durst R; Ibe UK; Shpitzen S; Schurr D; Eliav O; Futema M; Whittall R; Szalat A; Meiner V; Knobler H; Gavish D; Henkin Y; Ellis A; Rubinstein A; Harats D; Bitzur R; Hershkovitz B; Humphries SE; Leitersdorf E
Atherosclerosis; 2017 Feb; 257():55-63. PubMed ID: 28104544
[TBL] [Abstract][Full Text] [Related]
17. Lipid phenotype and heritage pattern in families with genetic hypercholesterolemia not related to LDLR, APOB, PCSK9, or APOE.
Jarauta E; Pérez-Ruiz MR; Pérez-Calahorra S; Mateo-Gallego R; Cenarro A; Cofán M; Ros E; Civeira F; Tejedor MT
J Clin Lipidol; 2016; 10(6):1397-1405.e2. PubMed ID: 27919357
[TBL] [Abstract][Full Text] [Related]
18. Double-heterozygous autosomal dominant hypercholesterolemia: Clinical characterization of an underreported disease.
Sjouke B; Defesche JC; Hartgers ML; Wiegman A; Roeters van Lennep JE; Kastelein JJ; Hovingh GK
J Clin Lipidol; 2016; 10(6):1462-1469. PubMed ID: 27919364
[TBL] [Abstract][Full Text] [Related]
19. New Sequencing technologies help revealing unexpected mutations in Autosomal Dominant Hypercholesterolemia.
Elbitar S; Susan-Resiga D; Ghaleb Y; El Khoury P; Peloso G; Stitziel N; Rabès JP; Carreau V; Hamelin J; Ben-Djoudi-Ouadda A; Bruckert E; Boileau C; Seidah NG; Varret M; Abifadel M
Sci Rep; 2018 Jan; 8(1):1943. PubMed ID: 29386597
[TBL] [Abstract][Full Text] [Related]
20. Novel PCSK9 (Proprotein Convertase Subtilisin Kexin Type 9) Variants in Patients With Familial Hypercholesterolemia From Cape Town.
Huijgen R; Blom DJ; Hartgers ML; Chemello K; Benito-Vicente A; Uribe KB; Behardien Z; Blackhurst DM; Brice BC; Defesche JC; de Jong AG; Jooste RJ; Solomon GAE; Wolmarans KH; Hovingh GK; Martin C; Lambert G; Marais AD
Arterioscler Thromb Vasc Biol; 2021 Feb; 41(2):934-943. PubMed ID: 33147992
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
